Affiliation:
1. Medical College of Soochow University
2. The affiliated Xuzhou Oriental Hospital of Xuzhou Medical University
3. The Fourth People’s Hospital of Lianyungang, The Affiliated KangDa College of Nanjing Medical University
4. Institute of Mental Health, The Affiliated Guangji Hospital of Soochow University
Abstract
Abstract
Background: Accumulating evidence has indicated that oxidative stress (OS) and matrix metalloproteinase-9 (MMP-9) may contribute to the mechanism of schizophrenia. In the present study, we aimed to evaluate the associations of OS parameters and MMP-9 levels with psychopathological symptoms in male chronic schizophrenia patients.
Methods: Plasma hydrogen peroxide (H2O2), malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), serum matrix metalloproteinase-9 (MMP-9), and tissue inhibitors of metalloproteinases-1 (TIMP-1) levels were assayed in 80 male patients with chronic schizophrenia and 80 matched healthy controls. Schizophrenia symptoms were assessed by the Positive and Negative Syndrome Scale (PANSS).
Results: Our results demonstrated that levels of antioxidant enzymes, SOD, GSH-Px, H2O2, and MDA were significantly decreased, whereas CAT and MMP-9 levels were increased in patients with schizophrenia, when compared with healthy controls (all P < 0.05). In schizophrenia patients, correlation analyses showed that H2O2 levels were significantly and positively correlated with PANSS positive scores, CAT and MDA levels were significant negatively correlated with PANSS negative scores and PANSS total scores, and MDA levels were significantly positively correlated with MMP-9 levels (all P < 0.05). However, we did not find that MMP-9 played an interaction role between OS parameters and PANSS total scores and subscales scores (all P > 0.05).
Conclusions: Our results showed that alterations of plasma OS parameters in male patients with chronic schizophrenia were associated with psychopathology and MMP-9, suggesting that OS and neuroinflammation may play important role in the mechanism of schizophrenia.
Publisher
Research Square Platform LLC
Reference54 articles.
1. Jauhar S, Johnstone M, McKenna PJ, Schizophrenia. The Lancet. 2022;399(10323):473–86.
2. The burden of mental, neurological, and substance use disorders in China and India: a systematic analysis of community representative epidemiological studies;Charlson FJ;Lancet,2016
3. Global regional. and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Psychiatry 2022, 9(2):137–150.
4. Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016;Charlson FJ;Schizophr Bull,2018
5. Targeting Molecular Mediators of Ferroptosis and Oxidative Stress for Neurological Disorders;Li J;Oxidative Med Cell Longev,2022